Rebecca Ronsley, MD
Seattle Children's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rebecca Ronsley, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05768880 · Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System TumorsSeattle Children's Hospital · active not recruiting · Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult · study chair
- Ph1NCT04185038 · Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsSeattle Children's Hospital · recruiting · Central Nervous System Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma · study chair
- Ph1NCT03500991 · HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsSeattle Children's Hospital · active not recruiting · Central Nervous System Tumor, Pediatric, Glioma, Ependymoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).